← FDA DRUG APPROVALS

FDA ANDA · ANDA201508

MONTELUKAST SODIUM

Sponsor: APOTEX INC

APPLICATION
ANDA201508
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-03
LATEST ACTION
2015-03-16
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

MONTELUKAST SODIUMDiscontinued
MONTELUKAST SODIUM EQ 4MG BASE · TABLET, CHEWABLE · ORAL
MONTELUKAST SODIUMDiscontinued
MONTELUKAST SODIUM EQ 5MG BASE · TABLET, CHEWABLE · ORAL

Approval history

2015-03-16Labeling · Supplement 7 · standardAP
2015-03-16Labeling · Supplement 5 · standardAP
2013-08-14Labeling · Supplement 4 · standardAP
2012-12-13Labeling · Supplement 1 · standardAP
2012-08-03Not Applicable · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →